Fundraising Fox

Scott Biller

Investor

Executive Venture Partner at GV (Google Ventures)

Boston, Massachusetts

Writes $250K – $50M checks · typically $25M

About

Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.

Invests in

BiotechMedical Devices

Experience

  1. OMass TherapeuticsBoard Membercurrent2022 — present
  2. GVExecutive Venture Partnercurrent2021 — presentCambridge, Massachusetts, United States
  3. ROME TherapeuticsBoard Membercurrent2021 — present
  4. Gate BioscienceBoard Observercurrent2021 — present
  5. Remix TherapeuticsBoard Membercurrent2020 — present
  6. Foghorn Therapeutics, IncBoard Membercurrent2020 — present
  7. VividionScientific Advisory Board member2019 — 2024
  8. Agios PharmaceuticalsScientific Advisory Board member2021 — 2023
  9. Agios PharmaceuticalsStrategic Advisor2020 — 2021
  10. Agios PharmaceuticalsChief Scientific Officer2010 — 2019
  11. Denali TherapeuticsScientific Advisory Board member2015 — 2023
  12. Novartis Institutes for BioMedical ResearchVice President, Global Discovery Chemistry2003 — 2010
  13. Bristol-Myers SquibbVice President, Pharmaceutical Candidate Optimization2001 — 2003
  14. Bristol Myers SquibbDirector, Executive Director, Discovery Chemistry1995 — 2001
  15. MITStudent1972 — 1976

Skills & more

Drug Discovery99Medicinal Chemistry56Drug Design40Organic Chemistry52Oncology34Chemistry99Drug Development99Lead Change24Lifesciences16Pharmacology27Cancer12Biochemistry27
+7 moreADMEAssay DevelopmentNeuroscienceOrganic SynthesisLife SciencesPharmaceutical IndustryCRO

From Scott's professional profile.

Investments

Board seats

Foghorn TherapeuticsOMASS TherapeuticsRemix TherapeuticsRome Therapeutics

Per the firm's website.

Colleagues at GV (Google Ventures)

Andrew Wheeler
General Partner at GV (Google Ventures)
Anika Gupta
Investor at GV (Google Ventures)
Anika Gupta Vatsa
Principal at GV (Google Ventures)
Anthony Philippakis
Investor at GV (Google Ventures)
Ben Robbins
Investor at GV (Google Ventures)
Braden Kowitz
Investor at GV (Google Ventures)
Bradley Horowitz
Investor at Wisdom Ventures
Brendan Bulik-Sullivan
Investor at GV (Google Ventures)

Frequently asked questions

Who is Scott Biller?
Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.
Where does Scott Biller work?
Scott Biller is Executive Venture Partner at GV (Google Ventures).
What does Scott Biller invest in?
Scott Biller invests in Biotech, Medical Devices.
What check size does Scott Biller write?
Scott Biller typically writes checks of $250K – $50M.
What boards does Scott Biller sit on?
Scott Biller holds tracked board seats at Foghorn Therapeutics, OMASS Therapeutics, Remix Therapeutics, Rome Therapeutics.
Where did Scott Biller go to school?
Scott Biller studied at Massachusetts Institute of Technology (BS, Chemistry); Columbia University (Postdoc, Organic Chemistry); Caltech (PhD, Organic Chemistry).

Same school

Also attended Massachusetts Institute of Technology1,387

Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars

+ 1,381 more

Also attended Columbia University726

Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystErica VanInvestment Director at Intel Capital

+ 720 more

Also attended Caltech144

Shaun MaguirePartner at Sequoia CapitalDario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordSeth LieblichInvestment Team at 8VCMarkus EnzelbergerPartner at Versant VenturesWen HsiehFounding Managing Partner at Matter Venture Partners

+ 138 more

Also attended Stuyvesant High School72

Alfred LinPartner at Sequoia CapitalSarah TavelVenture Partner at BenchmarkHussein KanjiPartner at Hoxton VenturesBen FriedVenture Partner at Rally Ventures Management, LlcDan BorokCo-Founder and Managing Partner at NVP CapitalPaulina KarpisVice President, Platform at Long Ridge Equity Partners

+ 66 more

Shared employers

Also worked at OMass Therapeutics2

Diana BernsteinDirector at Northpond VenturesClaire BrownPartner at Oxford Science Enterprises

Also worked at Remix Therapeutics3

Kevin BittermanPartner at Atlas VentureJeff GoaterPartner at The Column GroupCindy XiongInvestor at Foresite Capital

Also worked at Foghorn Therapeutics, Inc2

Samantha BerrickExecutive Assistant at Frazier Life SciencesMichael MendelsohnInvestor at Broadview Ventures

Also worked at Novartis Institutes for BioMedical Research130

Rebecca JamesInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesSteve TregayManaging General Partner at Mission Biocapital

+ 124 more